๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Compound trial record
Trackers Drugs Trial finder
Compound · clinical trials

Lactulose

Source: ClinicalTrials.gov, U.S. National Library of Medicine — the 5 trials in our India and China registers that name Lactulose as an intervention. Synced 24 Sep 2026
5Trials tracked
3Recruiting now
4Lead sponsors
2Country registers
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 โ€” Top 14 finalist
Compiled from ClinicalTrials.gov registry records ยท Last verified ยท Editorial standards

Lactulose is named as a drug or biological intervention in 5 clinical trials in our India and China trial registers, 3 of which are recruiting. Lead sponsors include Institute of Liver and Biliary Sciences, India (2), Post Graduate Institute of Medical Education and Research, Chandigarh (1) and Nanchong Central Hospital (1). Registered phases: Not applicable and Phase 4. Conditions studied include Decompensated Liver Cirrhosis; Acute on Chronic Liver Failure; Hepatic Encephalopathy.

01

Clinical trials of Lactulose

5 trials
NCT IDStudyPhaseStatusLead sponsorRegister
NCT06538077 BCAA vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of HE (ClinicalTrials.gov ↗)
Hepatic Encephalopathy, Decompensated Cirrhosis, Minimal Hepatic Encephalopathy
Phase 4 Recruiting Post Graduate Institute of Medical Education and Research, Chandigarh India
NCT07002827 Effect of Single vs Repeated Cycles of a Combination of Granulocyte Colony Stimulating Factor and Darbepoetin vs Standard Medical Treatment on Immunometabolic Profile in Patient With Early Decompensated Cirrhosis.
Decompensated Liver Cirrhosis
Not applicable Recruiting Institute of Liver and Biliary Sciences, India India
NCT07589465 Oral Lactulose for Gastrointestinal Recovery After Complex Appendectomy (ClinicalTrials.gov ↗)
Ileus Postoperative, Gastrointestinal Function, Complicated Appendicitis
Not applicable Recruiting Nanchong Central Hospital China
NCT06808009 Goal Directed Ammonia Lowering Therapy in Hyperammonemic ACLF Patients With no Overt HE to Reduce Major Adverse Liver Related Outcomes (GOAL Trial) (ClinicalTrials.gov ↗)
Acute on Chronic Liver Failure
Not applicable Not yet open Institute of Liver and Biliary Sciences, India India
NCT06748638 Clinical Study on the Application of Lactulose Combined with Linaclotide in Bowel Preparation for Colonoscopy (ClinicalTrials.gov ↗)
Lactulose, Bowel Preparation
Phase 4 By invitation Haifeng Lan China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.

02

Conditions studied

10 conditions
Condition (as registered)Trials
Decompensated Liver Cirrhosis1
Acute on Chronic Liver Failure1
Hepatic Encephalopathy1
Decompensated Cirrhosis1
Minimal Hepatic Encephalopathy1
Ileus Postoperative1
Gastrointestinal Function1
Complicated Appendicitis1
Lactulose1
Bowel Preparation1
03

Sponsors

lead sponsor per trial
Lead sponsorTrials
Institute of Liver and Biliary Sciences, India2
Post Graduate Institute of Medical Education and Research, Chandigarh1
Nanchong Central Hospital1
Haifeng Lan1
04

Trials by country register

A trial with sites in more than one country appears in each of those registers.

How this page is built

Everything on this page is copied from public ClinicalTrials.gov registry records โ€” it is not written from memory, and nothing here describes how Lactulose works or whether it is effective. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Lactulose (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician โ€” our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us โ€” we correct promptly and log it.